4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000006
CEO bought 120,500 shares at an average $0.03 ($3,306)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
22 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-22 | Purchase : show line 1 in the form | +5,000 | $0.03 | $134 | 20,878,123 | D |
| 2019-01-22 | Purchase : show line 2 in the form | +5,000 | $0.03 | $134 | 20,883,123 | D |
| 2019-01-22 | Purchase : show line 3 in the form | +10,000 | $0.03 | $267 | 20,893,123 | D |
| 2019-01-22 | Purchase : show line 4 in the form | +5,000 | $0.03 | $135 | 20,898,123 | D |
| 2019-01-22 | Purchase : show line 5 in the form | +5,000 | $0.03 | $130 | 20,903,123 | D |
| 2019-01-22 | Purchase : show line 6 in the form | +5,000 | $0.03 | $130 | 20,908,123 | D |
| 2019-01-22 | Purchase : show line 7 in the form | +5,000 | $0.03 | $130 | 20,913,123 | D |
| 2019-01-22 | Purchase : show line 8 in the form | +10,000 | $0.03 | $260 | 20,923,123 | D |
| Open-market purchases · 120,500 sh · avg $0.03 · $3,306 | ||||||
Loading xslF345X03/primary_doc.xml…